Pay Paul William 4
4 · Edesa Biotech, Inc. · Filed Jul 30, 2019
Insider Transaction Report
Form 4
Pay Paul William
Director
Transactions
- Award
Stock Option (right to buy)
2019-07-26+1,820→ 32,399 totalExercise: $2.16Exp: 2027-09-26→ Common Shares (1,820 underlying)
Footnotes (4)
- [F1]Represents additional options to purchase common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa") and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders.
- [F2]All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.
- [F3]This option vests and becomes exercisable 1/3 on September 26, 2018, and monthly thereafter through September 26, 2020. This option was issued in replacement of an option to purchase shares of Edesa.
- [F4]In Canadian currency.